Source: Annual Congress 2010 - Parenchmya and bronchial carcinoma
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
O. Lukina, A. Speranskaya, V. Amosov, V. Zolotnitskaya, E. Bobrov (St. Petersberg, Russian Federation). Imaging in assessment of out-of-proportion pulmonary hypertension in patients with COPD. Eur Respir J 2010; 36: Suppl. 54, 409

Member's Comments

No comment yet.

Related content which might interest you: NT-proBNP in assessment of pulmonary hypertension in COPD patients Source: Annual Congress 2013 –COPD treatment Year: 2013 Impact of exacerbations on pulmonary arterial enlargement in patients with chronic obstructive pulmonary disease Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment Year: 2013 CT predictors of pulmonary hypertension in patients with severe COPD Source: International Congress 2018 – Evaluation of COPD and various diseases by different imaging modalities Year: 2018 Co-morbidities and pulmonary arterial hypertension (PAH) in COPD patients Source: International Congress 2016 – Comorbidities and exacerbations in COPD Year: 2016 Cardiopulmonary MR characteristics can estimate mPAP in COPD Source: International Congress 2016 – Pulmonary hypertension: the clinic I Year: 2016 Quantitative estimation of lung perfusion scintigraphy in patients with idiopathic pulmonary arterial hypertension, receiving bosentan treatment Source: Annual Congress 2013 –Pulmonary circulation: chronic thromboembolic pulmonary hypertension, imaging and biomarkers Year: 2013 Secondary pulmonary hypertension in patients with COPD Source: Eur Respir J 2007; 30: Suppl. 51, 348s Year: 2007 Acute and chronic effects of PDE5-Is on SpO2 in patients with COPD associated pulmonary hypertension Source: Annual Congress 2013 –Pulmonary circulation: clinical treatment Year: 2013 Stroke volume augmentation during exercise in patients with chronic obstructive pulmonary disease with and without pulmonary hypertension Source: Annual Congress 2010 - Pulmonary vascular diseases Year: 2010 Prevalence of pulmonary hypertension among COPD patients: screening by echocardiography and NT-PROBNP Source: Annual Congress 2009 - Pulmonary vascular diseases Year: 2009 Current management of patients with chronic thromboembolic pulmonary hypertension Source: Annual Congress 2010 - Pulmonary hypertension updates Year: 2010 Does pulmonary hypertension exclude pulmonary rehabilitation in patients with COPD? Source: International Congress 2017 – Best abstracts in pulmonary rehabilitation in patients with chronic lung diseases Year: 2017 Effects of Valsartan on pulmonary hemodynamics in patients with chronic obstructive pulmonary disease (COPD) and secondary pulmonary hypertension Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies Year: 2019 Diagnosis and treatment of secondary pulmonary hypertension in patients with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 404s Year: 2006 Conclusion: treatment of pulmonary hypertension in COPD patients Source: Annual Congress 2005 - COPD - pulmonary haemodynamics and gas exchange Year: 2005 Acquisition of echo-Doppler parameters of pulmonary hypertension in COPD Source: Annual Congress 2012 - Pulmonary circulation: clinical end-points and clinical physiology Year: 2012 Comparing cardiopulmonary responses to incremental exercise in patients with chronic thromboembolic pulmonary hypertension and idiopathic pulmonary arterial hypertension Source: Annual Congress 2011 - Altered mechanisms during exercise in disease Year: 2011 Therapeutic update of severe pulmonary hypertension in COPD Source: Annual Congress 2010 - Pulmonary vascular involvement in COPD Year: 2010 The comorbid patients with arterial hypertension and chronic obstructive pulmonary disease: Assessment of diastolic wall strain Source: International Congress 2014 – COPD and PAH related imaging Year: 2014 Evaluation of criteria for exercise-induced pulmonary hypertension in patients with resting pulmonary hypertension Source: Eur Respir J, 50 (3) 1700784; 10.1183/13993003.00784-2017 Year: 2017